Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tomasini

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biomacromolecules|June 7, 2013
Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptorsMichael D Tomasini, Kyle Zablocki, Latrisha K Petersen, et al.
The American Journal of Pathology|August 6, 1999
Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behaviorE Berti, D Tomasini, M H Vermeer, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1991
[Bullous pemphigoid and multiple sclerosis]D Tomasini, V Bonfacini, E Martin-Ortega, et al.
The British Journal of Dermatology|August 14, 2013
Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviourC Mitteldorf, M Bieri, N Wey, et al.
Scientific Reports|January 17, 2018
Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular CarcinomaMichael D Tomasini, Yingjie Wang, Adak Karamafrooz, et al.
Biomaterials|July 30, 2013
In silico design of anti-atherogenic biomaterialsDaniel R Lewis, Vladyslav Kholodovych, Michael D Tomasini, et al.
European Review for Medical and Pharmacological Sciences|August 4, 2020
The role of interventional radiotherapy (brachytherapy) in stage I esophageal cancer: an AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic reviewV Lancellotta, F Cellini, B Fionda, et al.
Science Advances|June 21, 2023
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinomaSolomon N Levin, Michael D Tomasini, James Knox, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biomacromolecules|June 7, 2013
Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptorsMichael D Tomasini, Kyle Zablocki, Latrisha K Petersen, et al.
The American Journal of Pathology|August 6, 1999
Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behaviorE Berti, D Tomasini, M H Vermeer, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1991
[Bullous pemphigoid and multiple sclerosis]D Tomasini, V Bonfacini, E Martin-Ortega, et al.
The British Journal of Dermatology|August 14, 2013
Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviourC Mitteldorf, M Bieri, N Wey, et al.
Scientific Reports|January 17, 2018
Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular CarcinomaMichael D Tomasini, Yingjie Wang, Adak Karamafrooz, et al.
Biomaterials|July 30, 2013
In silico design of anti-atherogenic biomaterialsDaniel R Lewis, Vladyslav Kholodovych, Michael D Tomasini, et al.
European Review for Medical and Pharmacological Sciences|August 4, 2020
The role of interventional radiotherapy (brachytherapy) in stage I esophageal cancer: an AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic reviewV Lancellotta, F Cellini, B Fionda, et al.
Science Advances|June 21, 2023
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinomaSolomon N Levin, Michael D Tomasini, James Knox, et al.
Pageof 2